ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.648,00
0,25%
Brent Oil
81,295
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Alvontech (ALVO)

  7. Alvontech (ALVO) Notícias

ALVO

Alvontech (ALVO)

Alvontech
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALVO
DataHoraFonteTítuloCódigoCompanhia
29/05/202409:05GlobeNewswire Inc.Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024NASDAQ:ALVOAlvontech
21/05/202418:15GlobeNewswire Inc.Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business UpdateNASDAQ:ALVOAlvontech
21/05/202411:05Business WireAlvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UKNASDAQ:ALVOAlvontech
21/05/202409:00GlobeNewswire Inc.Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UKNASDAQ:ALVOAlvontech
21/05/202408:13IH Market NewsU.S. Index Futures Open Lower Amid Nasdaq Record, Fed SpeechesNASDAQ:ALVOAlvontech
20/05/202421:25Business WireTeva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.NASDAQ:ALVOAlvontech
13/05/202409:00GlobeNewswire Inc.Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)NASDAQ:ALVOAlvontech
02/05/202408:15GlobeNewswire Inc.Alvotech Announces Participation at BofA Securities Healthcare Conference 2024NASDAQ:ALVOAlvontech
30/04/202405:00GlobeNewswire Inc.U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)NASDAQ:ALVOAlvontech
24/04/202405:00GlobeNewswire Inc.Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)NASDAQ:ALVOAlvontech
19/04/202407:10GlobeNewswire Inc.Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)NASDAQ:ALVOAlvontech
16/04/202418:43Business WireAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)NASDAQ:ALVOAlvontech
03/04/202408:41GlobeNewswire Inc.Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024NASDAQ:ALVOAlvontech
22/03/202417:15GlobeNewswire Inc.Alvotech Announces Increase in Number of Own SharesNASDAQ:ALVOAlvontech
20/03/202417:15GlobeNewswire Inc.Alvotech Reports Financial Results for Full Year 2023 and Provides a Business UpdateNASDAQ:ALVOAlvontech
20/03/202408:17IH Market NewsU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices DipNASDAQ:ALVOAlvontech
05/03/202418:00GlobeNewswire Inc.Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ETNASDAQ:ALVOAlvontech
29/02/202418:05GlobeNewswire Inc.Alvotech Appoints Interim Chief Quality OfficerNASDAQ:ALVOAlvontech
26/02/202406:25GlobeNewswire Inc.Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per ShareNASDAQ:ALVOAlvontech
23/02/202422:15GlobeNewswire Inc.Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®NASDAQ:ALVOAlvontech
23/02/202422:15Business WireAlvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®NASDAQ:ALVOAlvontech
15/02/202408:30GlobeNewswire Inc.Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)NASDAQ:ALVOAlvontech
29/01/202406:00GlobeNewswire Inc.Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®NASDAQ:ALVOAlvontech
19/01/202414:31Dow Jones NewsAlvotech Shares Climb After FDA Concludes Facility InspectionNASDAQ:ALVOAlvontech
19/01/202413:30GlobeNewswire Inc.Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04NASDAQ:ALVOAlvontech
10/01/202405:30GlobeNewswire Inc.STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to StelaraNASDAQ:ALVOAlvontech
03/01/202405:30GlobeNewswire Inc.Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)NASDAQ:ALVOAlvontech
29/11/202306:00GlobeNewswire Inc.Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®NASDAQ:ALVOAlvontech
28/11/202318:15GlobeNewswire Inc.Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business UpdateNASDAQ:ALVOAlvontech
21/11/202310:00GlobeNewswire Inc.Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Host Business Update Conference Call on November 29, 2023, at 8:00 am ETNASDAQ:ALVOAlvontech
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALVO

Seu Histórico Recente

BIT
UB7HNH
Unicredit Bank
USOTC
DMWAF
D M Wenceslao and Associ... (GM)
BIT
W7B980
Unicredit Bank
BIT
UIJ073
Unicredit Bank
BIT
S27447
Societe Generale Effekten
TSXV
META
Meta Growth
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados